Table of Contents
SBI Magnum mid cap fund and L&T Midcap Fund both belong to the Mid Cap Category of Equity Funds. Both these schemes invest their accumulated fund money in equity and equity-related instruments of companies having a Market capitalization between INR 500 – INR 10,000 Crores. Though both the schemes belong to the same category yet; there are differences with respect to their performance, AUM, current NAV, and many other related factors. So, let us understand the differences between SBI Magnum Mid Cap Fund and L&T Midcap Fund through this article.
SBI Mid Cap Fund is offered by SBI Mutual Fund under Mid Cap category. It is an open-ended scheme which was launched on March 29, 2005. The scheme’s objective is to attain Capital growth in long-term by Investing in equity and equity-related instruments of Mid Cap companies. The scheme uses Nifty MidSmallcap 400 Index to construct its Portfolio.
The top 10 holdings of SBI Magnum Mid Cap Fund’s portfolio include Cholamandalam Investment and Finance Company Limited, Dixon Technologies (India) Limited, Sheela Foam Limited, and Federal Bank Limited.
The fund is suitable for investors looking for capital appreciation for long-term tenure. The scheme follows bottom-up approach of stock selection.
L&T Midcap Fund is an open-ended equity fund which was incepted on August 09, 2004. The fund house who owns the L&T Midcap Fund is L&T Mutual Fund. The scheme’s objective is to attain capital appreciation by investing in shares of Mid Cap companies. The scheme uses Nifty Free Float Midcap 100 Index to construct its portfolio.
The top 10 constituents of L&T Mid Cap Fund’s portfolio include Sundaram Finance Limited, IndusInd Bank Limited, Union Bank of India, Canara Bank, Oberoi Realty Limited, and much more.
The parameters or elements that are used to compare both the scheme are divided into four categories, namely, basic section, performance section, yearly performance section, and other details section. So, let us have a look at each of these parameters and see how the funds stand against each other.
The elements compared in this section include Category of Scheme, Fincash Rating, Current NAV, AUM, expense ratio and much more. To begin with the scheme’s category, we can see that both the schemes belong to the same category, that is, Equity Mid Cap.
Fincash Rating, it can be said that L&T Midcap Fund has a 4-Star rating, while SBI Magnum Mid Cap Fund has 3-Star rating.
The following table summarizes the various comparison components of the basics section.
Parameters Basics NAV Net Assets (Cr) Launch Date Rating Category Sub Cat. Category Rank Risk Expense Ratio Sharpe Ratio Information Ratio Alpha Ratio Benchmark Exit Load SBI Magnum Mid Cap Fund
Growth
Fund Details ₹229.779 ↑ 1.78 (0.78 %) ₹21,407 on 31 Oct 24 29 Mar 05 ☆☆☆ Equity Mid Cap 28 Moderately High 1.77 1.93 -0.48 1.23 Not Available 0-1 Years (1%),1 Years and above(NIL) Essel Long Term Advantage Fund
Growth
Fund Details ₹28.522 ↑ 0.39 (1.38 %) ₹62 on 31 Oct 24 30 Dec 15 Equity ELSS Moderately High 2.11 1.33 -1.17 -6.29 Not Available NIL
As the name mentions, this scheme compares the CAGR performance of both the schemes at various time frames. Some of the timeframes for which the performance is compared are 1 Month, 3 Months, 1 Year, 5 Years, and Since Inception. When we look at the performance of both the schemes in almost all the time periods, L&T Midcap Fund has performed better as compared to SBI Magnum Mid Cap Fund. However, the difference between both the schemes is not much. The table given below tabulates the performance of both the schemes at different timeframes.
Parameters Performance 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year Since launch SBI Magnum Mid Cap Fund
Growth
Fund Details -3.3% -4.7% 6.7% 24.2% 18.1% 26.8% 17.3% Essel Long Term Advantage Fund
Growth
Fund Details -1.2% -5.3% 5.8% 20.2% 11.3% 14.3% 12.5%
Talk to our investment specialist
This category gives the absolute performance of both the schemes on a yearly Basis. Here, too we can say that; L&T Midcap Fund’s performance is better as compared to SBI Magnum Mid Cap Fund in many instances. The yearly performance of both the schemes is tabulated as follows.
Parameters Yearly Performance 2023 2022 2021 2020 2019 SBI Magnum Mid Cap Fund
Growth
Fund Details 34.5% 3% 52.2% 30.4% 0.1% Essel Long Term Advantage Fund
Growth
Fund Details 24.1% -2% 29.4% 8.5% 7.9%
This section is the last section in case of comparison between both the schemes. Some of the comparison elements that form part of this section include, Minimum SIP Investment and Minimum Lumpsum Investment. The Minimum SIP investment in case of both the schemes is same, that is, INR 500. Similarly, the Minimum Lumpsum Investment is also same for both the schemes, that is, INR 5,000.
SBI Magnum Mid Cap Fund is managed by Ms Sohini Andani.
The Fund Managers managing the L&T Midcap Fund are Mr. S. N. Lahiri and Mr. Vihang Naik.
The table given below summarizes the elements of other details section.
Parameters Other Details Min SIP Investment Min Investment Fund Manager SBI Magnum Mid Cap Fund
Growth
Fund Details ₹500 ₹5,000 Bhavin Vithlani - 0.59 Yr. Essel Long Term Advantage Fund
Growth
Fund Details ₹500 ₹500 Aditya Mulki - 2.65 Yr.
SBI Magnum Mid Cap Fund
Growth
Fund Details Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹10,825 31 Oct 21 ₹19,310 31 Oct 22 ₹21,129 31 Oct 23 ₹24,978 31 Oct 24 ₹33,559 Essel Long Term Advantage Fund
Growth
Fund Details Growth of 10,000 investment over the years.
Date Value 31 Oct 19 ₹10,000 31 Oct 20 ₹9,506 31 Oct 21 ₹14,326 31 Oct 22 ₹14,116 31 Oct 23 ₹15,580 31 Oct 24 ₹19,769
SBI Magnum Mid Cap Fund
Growth
Fund Details Asset Allocation
Asset Class Value Cash 5.9% Equity 94.1% Equity Sector Allocation
Sector Value Consumer Cyclical 20.67% Financial Services 19.86% Industrials 16.5% Health Care 11.3% Basic Materials 7.92% Utility 4% Real Estate 3.96% Technology 3.74% Communication Services 2.86% Consumer Defensive 1.95% Energy 1.33% Top Securities Holdings / Portfolio
Name Holding Value Quantity CRISIL Ltd (Financial Services)
Equity, Since 30 Apr 21 | CRISIL4% ₹876 Cr 1,600,000
↑ 25,478 Torrent Power Ltd (Utilities)
Equity, Since 30 Jun 19 | 5327794% ₹856 Cr 4,700,000
↓ -70,722 Sundaram Finance Ltd (Financial Services)
Equity, Since 30 Sep 22 | SUNDARMFIN3% ₹716 Cr 1,490,000 Voltas Ltd (Industrials)
Equity, Since 30 Apr 24 | VOLTAS3% ₹660 Cr 4,000,000 Thermax Ltd (Industrials)
Equity, Since 31 Dec 13 | THERMAX3% ₹591 Cr 1,200,000 Coromandel International Ltd (Basic Materials)
Equity, Since 31 Jan 18 | 5063953% ₹584 Cr 3,500,000 K.P.R. Mill Ltd (Consumer Cyclical)
Equity, Since 31 Oct 22 | KPRMILL3% ₹561 Cr 6,000,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH3% ₹560 Cr 5,500,000 Bajaj Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | 5000343% ₹551 Cr 800,000
↑ 200,000 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 12 | FEDERALBNK3% ₹551 Cr 27,000,000 Essel Long Term Advantage Fund
Growth
Fund Details Asset Allocation
Asset Class Value Cash 13.37% Equity 86.63% Equity Sector Allocation
Sector Value Financial Services 27.78% Industrials 11.25% Health Care 10.11% Technology 9.84% Consumer Defensive 9.3% Basic Materials 5.46% Communication Services 4.48% Consumer Cyclical 4.46% Energy 3.96% Top Securities Holdings / Portfolio
Name Holding Value Quantity HDFC Bank Ltd (Financial Services)
Equity, Since 31 Dec 15 | HDFCBANK6% ₹4 Cr 21,500 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 20 | BHARTIARTL4% ₹3 Cr 16,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Dec 19 | RELIANCE4% ₹2 Cr 18,536 Persistent Systems Ltd (Technology)
Equity, Since 31 Jul 22 | PERSISTENT4% ₹2 Cr 4,400 Infosys Ltd (Technology)
Equity, Since 30 Apr 20 | INFY4% ₹2 Cr 13,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 22 | MAXHEALTH4% ₹2 Cr 22,000 SBI Life Insurance Co Ltd (Financial Services)
Equity, Since 31 Jan 22 | SBILIFE4% ₹2 Cr 13,500 Hindustan Aeronautics Ltd Ordinary Shares (Industrials)
Equity, Since 30 Sep 22 | HAL3% ₹2 Cr 5,000 Rec Limited
Debentures | -3% ₹2 Cr 200,000 Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 28 Feb 21 | SUNPHARMA3% ₹2 Cr 10,500
Thus, from the above elements, it can be said that both the schemes differ on account of various parameters. However, it is always advised to individuals to understand a scheme’s modalities completely before investing. They should check if the fund’s objective is in-line with theirs. They should also check various parameters such as returns, Underlying asset portfolio, fund manager managing the scheme and much more. Additionally, they can take help of a financial advisor, if required. Through this individual can ensure that their money is safe and their objectives are met timely.